12006498 | Composition for regulating expression of PROX1 or expression of telomerase reverse transcriptase comprising activity regulator or method for screening telomerase reverse transcriptase regulator | Oct 19, 18 | Jun 11, 24 | Korea Institute of Science and Technology; INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY; |
11998541 | Method for alleviating chronic liver disease using Rosoxacin | Nov 11, 22 | Jun 04, 24 | NATIONAL YANG MING CHIAO TUNG UNIVERSITY |
11999718 | Pyrazole derivatives | Jan 06, 23 | Jun 04, 24 | APTABIO THERAPEUTICS INC. |
11999722 | Disubstituted pyrazole compounds | Sep 17, 21 | Jun 04, 24 | Applied Molecular Evolution Inc. c/o Eli Lilly and Company Patent Division |
11992499 | Quinoline derivatives for use in the treatment of inflammation diseases | Dec 19, 19 | May 28, 24 | ABIVAX; (1) Imstar Image et Modelisation: Strategie Analyse et Realisation (2) Institut Curie (et al); UNIVERSITE DE MONTIPELLIER; Centre National De La Recherche Scientifique (CNRS); |
11986501 | Treatment methods and compositions | Jul 16, 19 | May 21, 24 | UNM Rainforest Innovations |
11987791 | Compositions and methods for modulating hepatocyte nuclear factor 4-alpha (HNF4α) gene expression | Sep 23, 20 | May 21, 24 | Omega Therapeutics, Inc. |
11980672 | Heterologous UTR sequences for enhanced mRNA expression | Jun 21, 22 | May 14, 24 | ModernaTX, Inc. |
11975046 | Medical use of interferon-lambda for the treatment of fibrosis | Jun 29, 23 | May 07, 24 | UCB Biopharma SRL; Five Prime Therapeutics, Inc.; |
11976096 | Antibody-evading virus vectors | Sep 26, 23 | May 07, 24 | Ginkgo BioWorks, Inc. |
11970484 | LXR modulators with bicyclic core moiety | Feb 09, 23 | Apr 30, 24 | OrsoBio, Inc. |
11970523 | Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof | May 06, 19 | Apr 30, 24 | China Pharmaceutical University |
11963961 | Combination therapy comprising an ACC inhibitor | Mar 17, 21 | Apr 23, 24 | Gilead Sciences, Inc. |
11963989 | Application of medical cell CMU-pb-7 in preparation of blood lipid-lowering drugs | Jun 17, 23 | Apr 23, 24 | GUANGDONG XINGHAI BIOTECHNOLOGY CO., LTD.; GUANGDONG XINGHAI INSTITUTE OF CELL; |
11964960 | Pyridinone- and pyridazinone-based compounds and uses thereof | Mar 08, 19 | Apr 23, 24 | Cornell University; Tri-Institutional Therapeutics Discovery Institute; |
11965034 | Antifibrotic activity of CD47 blockade in the liver | Feb 09, 22 | Apr 23, 24 | The Board of Trustees of the Leland Stanford Junior University |
11957687 | Modulators of HSD17B13 and methods of use thereof | Jul 01, 20 | Apr 16, 24 | Regeneron Pharmaceuticals, Inc. |
11957704 | Methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta E (INHBE) inhibitors | Aug 31, 22 | Apr 16, 24 | Regeneron Pharmaceuticals, Inc. |
11938122 | 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3- thiazolidine-2,4-dione for treating nonalcoholic fatty liver disease | Dec 01, 17 | Mar 26, 24 | Minoryx Therapeutics S.L. |
11938172 | Method for regulating and controlling GLP-1/GLP-1R and drug | Jun 19, 18 | Mar 26, 24 | TALENGEN INTERNATIONAL LIMITED |